A M Heagerty

Author PubWeight™ 89.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Influence of cimetidine on pharmacokinetics of propranolol. Br Med J (Clin Res Ed) 1981 2.50
2 Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 1995 2.28
3 Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 2006 2.22
4 Vascular remodeling. Hypertension 1996 1.99
5 Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003 1.93
6 The amplifier hypothesis: permission to dissent? J Hypertens 1999 1.73
7 Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986 1.65
8 Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995 1.62
9 Salt and hypertension. Lancet 1984 1.52
10 31P nuclear magnetic resonance measurement of free erythrocyte magnesium concentration in man and its relation to blood pressure. Clin Sci (Lond) 1988 1.40
11 Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 2004 1.29
12 Leucocyte membrane sodium transport in normotensive populations: dissociation of abnormalities of sodium efflux from raised blood-pressure. Lancet 1982 1.26
13 Failure of ranitidine to interact with propranolol. Br Med J (Clin Res Ed) 1982 1.18
14 Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987 1.13
15 Influence of dietary linoleic acid on leucocyte sodium transport and blood pressure. Br Med J (Clin Res Ed) 1986 1.11
16 The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 2002 1.11
17 Cimetidine and bioavailability of propranolol. Lancet 1981 1.08
18 Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 2001 1.04
19 Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 2007 1.01
20 Myogenic tone in mesenteric arteries from spontaneously hypertensive rats. Am J Physiol 1996 1.01
21 Abnormal vascular phosphoinositide hydrolysis in the spontaneously hypertensive rat. Br J Pharmacol 1986 1.01
22 Membrane-associated diacylglycerol kinase activity is increased by noradrenaline, but not by angiotensin II, in arterial smooth muscle. Biochem J 1994 1.01
23 Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol 1995 0.99
24 Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993 0.98
25 Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. Curr Cardiol Rev 2012 0.98
26 Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. Br J Clin Pharmacol 1987 0.94
27 Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 1997 0.93
28 Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 1996 0.90
29 Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 2007 0.89
30 Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries. Br J Pharmacol 1997 0.89
31 Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin. Br J Pharmacol 2013 0.89
32 Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects. Br J Clin Pharmacol 1988 0.88
33 Lipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function. Acta Physiol Scand 1998 0.87
34 Studies of isolated resistance vessels from offspring of essential hypertensive patients. Hypertension 1987 0.87
35 Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer. Br J Cancer 1988 0.87
36 In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993 0.85
37 Impaired flow-dependent dilatation in distal mesenteric arteries from the spontaneously hypertensive rat. J Physiol 1999 0.85
38 Calcium antagonists in hypertension: relation to abnormal sodium transport. Br Med J (Clin Res Ed) 1983 0.85
39 Neurotransmission in human resistance arteries: contribution of alpha 1- and alpha 2-adrenoceptors but not P 2-purinoceptors. J Vasc Res 1992 0.85
40 Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats. Circ Res 1991 0.85
41 Effects of treatment for hypertension on cerebral haemorrhage and infarction. Br Med J (Clin Res Ed) 1984 0.84
42 Endothelin-1 stimulates hydrolysis of phosphatidylcholine by phospholipases C and D in intact rat mesenteric arteries. J Vasc Res 1999 0.84
43 Adenosine and hypoxic dilation of rat coronary small arteries: roles of the ATP-sensitive potassium channel, endothelium, and nitric oxide. Am J Physiol Heart Circ Physiol 2005 0.83
44 Cell membrane sodium transport: a correlation between human resistance vessels and leucocytes. Lancet 1986 0.83
45 Noradrenaline stimulation of the phosphoinositide system: evidence for a novel hydrophobic inositol-containing compound in resistance arterioles. Br J Pharmacol 1988 0.83
46 A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer. Gene Ther 2003 0.82
47 The addition of prazosin to standard triple therapy in the treatment of severe hypertension. Br J Clin Pharmacol 1982 0.82
48 Phospholipase D-induced phosphatidate production in intact small arteries during noradrenaline stimulation: involvement of both G-protein and tyrosine-phosphorylation-linked pathways. Biochem J 1995 0.81
49 Changes in leucocyte sodium transport in normotensive relatives of hypertensive subjects. Dissociation from blood pressure. Hypertension 1984 0.81
50 The contractile effects of porcine tetradecapeptide renin substrate in human resistance vessels: evidence of activation by vascular wall renin and serine proteases. J Hypertens 1989 0.81
51 Membrane transport of ions in hypertension: a review. Scand J Clin Lab Invest Suppl 1986 0.80
52 In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994 0.80
53 Resistance artery phosphoinositide metabolism in genetic hypertension. J Hypertens 1990 0.80
54 Effects of manipulation of sodium balance on erythrocyte sodium transport. J Hum Hypertens 1987 0.80
55 Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia. Am J Physiol 1998 0.79
56 Increased wall-lumen ratio of mesenteric vessels from the spontaneously hypertensive rat is not associated with increased contractility under isobaric conditions. Hypertension 1996 0.79
57 Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Press 1993 0.79
58 International Society of Hypertension Low and Middle Income Countries Committee: Review of the goals of the Committee and of 5 years of ISH activities in low and middle income countries. J Hypertens 2010 0.79
59 In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995 0.79
60 Intracellular pH in rat resistance arteries during the development of experimental hypertension. Clin Sci (Lond) 1991 0.79
61 Arterial neuroeffector responses in early and mature spontaneously hypertensive rats. Hypertension 1991 0.79
62 Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension. J Hum Hypertens 1987 0.79
63 Intracellular pH in human resistance arteries in essential hypertension. Hypertension 1991 0.78
64 Effect of experimental hypertension on phosphoinositide hydrolysis and proto-oncogene expression in cardiovascular tissues. J Vasc Res 1993 0.78
65 Relationship of endothelial function and atherosclerosis to treatment response in late-life depression. Int J Geriatr Psychiatry 2012 0.78
66 Effect of dietary polyunsaturated fatty acids on contraction and relaxation of rat femoral resistance arteries. J Cardiovasc Pharmacol 1994 0.78
67 Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats. Hypertension 1997 0.78
68 Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Br J Pharmacol 1991 0.78
69 Endothelial-dependent relaxation in human subcutaneous resistance vessels. Blood Vessels 1987 0.78
70 Ion transport in hypertension: are changes in the cell membrane responsible? Clin Sci (Lond) 1986 0.77
71 Mechanical properties of porcine small coronary arteries in one-kidney, one-clip hypertension. J Vasc Res 1996 0.77
72 Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis. Int J Exp Pathol 2001 0.77
73 The expression of cartilage oligomeric matrix protein, thrombospondin-1, bone sialoprotein and osteopontin in calcified and non-calcified arterial lesions. Biochem Soc Trans 1998 0.77
74 In vitro characteristics of vessels from patients with essential hypertension. J Clin Hypertens 1987 0.77
75 The effect of dietary linoleic acid on blood pressure and erythrocyte sodium transport. J Hum Hypertens 1989 0.77
76 Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries. Hypertension 1996 0.77
77 Small artery structural alterations of patients with microvascular angina (syndrome X). Clin Sci (Lond) 1996 0.77
78 Membrane handling of calcium in essential hypertension. J Hypertens Suppl 1987 0.76
79 Erythrocyte phosphoinositide metabolism in essential hypertensive patients and their normotensive offspring. Clin Sci (Lond) 1987 0.76
80 Dietary changes in membrane lipids and leucocyte calcium. J Cardiovasc Pharmacol 1988 0.76
81 Erythrocyte membrane calcium binding in normotensive and hypertensive subjects. J Hypertens Suppl 1986 0.76
82 Nifedipine infusion in acute myocardial infarction: experience in twelve patients. Clin Cardiol 1987 0.76
83 The combination of verapamil and captopril in the treatment of essential hypertension. Pharmatherapeutica 1987 0.76
84 Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT. Am J Cardiol 1995 0.76
85 n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction. Heart 2009 0.76
86 Oestrogen and women's heart disease: ESPRIT-UK. QJM 2000 0.76
87 The measurement of internal pH in resistance arterioles: evidence that intracellular pH is more alkaline in SHR than WKY animals. J Hypertens 1989 0.76
88 Transfection of cardiac muscle: effects of overexpression of c-myc and c-fos proto-oncogene proteins in primary cultures of neonatal rat cardiac myocytes. Clin Sci (Lond) 1997 0.76
89 Myogenic tone in coronary arteries from spontaneously hypertensive rats. J Vasc Res 1997 0.76
90 Regulation of beta myosin heavy chain, c-myc and c-fos proto-oncogenes in thyroid hormone-induced hypertrophy of the rat myocardium. Clin Sci (Lond) 1993 0.76
91 Leukocyte ionized calcium and sodium content and blood pressure in humans. Hypertension 1986 0.76
92 Endothelin-induced contraction of human peripheral resistance vessels is partly dependent on stimulation of sodium-hydrogen exchange. J Hypertens 1990 0.75
93 Consultants' workload in outpatient clinics. Existing outpatient services could be more efficient. BMJ 1995 0.75
94 Inadequacy of oleic acids in erythrocytes as a marker for malignancies. Br Med J (Clin Res Ed) 1987 0.75
95 Aortic dissection with chronic haemopericardium. J R Soc Med 1999 0.75
96 Gene therapy made difficult. Heart 1999 0.75
97 Noradrenaline: a circulating inhibitor of sodium transport. Br Med J (Clin Res Ed) 1984 0.75
98 Aneurysm of anterior communicating artery masquerading as Adams-Stokes disease. Br Med J (Clin Res Ed) 1984 0.75
99 Vascular renin-angiotensin system: the unanswered questions. J Hypertens Suppl 1987 0.75
100 Cell membrane handling of sodium, sodium balance, and blood pressure. J Cardiovasc Pharmacol 1984 0.75
101 Nifedipine and/or atenolol for mild to moderate hypertension: a general practice study. Cardiovasc Drugs Ther 1989 0.75
102 Hypertension and the vasculature: arterioles and the myogenic response. J Hypertens 1995 0.75
103 A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995 0.75
104 Salt and hypertension. Lancet 1984 0.75
105 Structure and in vitro function of human subcutaneous small arteries in mild heart failure. Am J Physiol 1998 0.75
106 Sodium efflux and essential hypertension. Lancet 1982 0.75
107 Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT). J Hypertens Suppl 1993 0.75
108 Vasopressin-mediated contractions in mesenteric arteries from spontaneously hypertensive rats: differences in response compared with Wistar-Kyoto animals. Clin Sci (Lond) 1988 0.75
109 [OP.5A.07] THE ROLE OF SYMPATHETIC NERVES AND NORADRENERGIC TRANSMISSION IN PERIVASCULAR ADIPOSE TISSUE FUNCTION. J Hypertens 2016 0.75
110 Effects of changes in sodium balance on leucocyte sodium transport: qualitative differences in normotensive offspring of hypertensives and matched controls. J Hypertens 1986 0.75
111 The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart. Cardiovasc Res 1996 0.75
112 Relaxation of isolated resistance vessels from humans with vascular disease. Acta Med Scand Suppl 1986 0.75
113 Linoleic acid supplementation, membrane lipids and leucocyte sodium transport in normotensive humans. J Hum Hypertens 1989 0.75
114 The effects of coarctation hypertension upon vascular inositol phospholipid hydrolysis in Wistar rats. J Hypertens 1988 0.75
115 Influence of arterial diameter on vasomotor responses in the porcine coronary vasculature. Cardiovasc Res 1994 0.75
116 The effect of short chain fatty acid supplementation on membrane electrolyte transport and blood pressure. J Hum Hypertens 1990 0.75
117 Effect of one-kidney, one clip hypertension on the structure and function of porcine intramyocardial small arteries. J Hypertens 1995 0.75
118 Effect of cold pressor test-induced stress on leukocyte sodium transport and norepinephrine. Hypertension 1987 0.75
119 The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects. J Hum Hypertens 1988 0.75
120 Evidence for a decreased noradrenaline sensitivity in mesenteric resistance vessels from rats with chemical renal medullectomy. Clin Sci (Lond) 1989 0.75
121 Blood pressure parameters as determinants of small artery structure in human essential hypertension. Clin Sci (Lond) 1997 0.75
122 Treatment of essential hypertension: changes in blood pressure, echocardiography and electrocardiography on three therapeutic regimes. Eur J Clin Pharmacol 1985 0.75
123 The phosphoinositide signaling system and hypertension. Curr Opin Nephrol Hypertens 1992 0.75
124 Phosphoinositide hydrolysis is not enhanced by ciclosporin. Nephron 1991 0.75
125 Sodium transport and hypertension. Lancet 1983 0.75
126 Resting intracellular pH in mesenteric resistance arteries from spontaneously hypertensive and Wistar-Kyoto rats: effects of amiloride and 4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid. J Hypertens Suppl 1989 0.75
127 Atrial flutter: the dangers of cardioversion. Int J Cardiol 2001 0.75
128 Diacylglycerol kinase activity in intact small arteries. Biochem Soc Trans 1993 0.75
129 Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens 1991 0.75
130 Rat thymocyte sodium transport. Effects of changes in sodium balance and experimental hypertension. Hypertension 1984 0.75